Loading institutional data...
Loading institutional data...
Strong institutional accumulation: ownership increased +13.34% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $11.23 today, the market must believe free cash flow compounds 13.2%/yr for a decade (off $3M normalized FCF).
2-stage DCF · 0.01B shares · net debt -$10M
mean 32.7% · volatility σ 178% · implied rate exceeded in 4/8 yrs
Central path = implied 13.2%/yr growth; shaded band = ±1σ (178%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$596000 FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $11M covers all $2M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2022-06-30 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~6.6% on $684000 of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.5M 100.0% | $42.3M 100.0% | $43.3M 100.0% | $44.1M 100.0% | $32.5M 100.0% | $34.5M 100.0% | $39.2M 100.0% | $42.4M 100.0% | $38.5M 100.0% | $34.5M 100.0% |
| Cost of Revenue | $27.3M 74.9% | $31.6M 74.6% | $31.5M 72.9% | $32.3M 73.4% | $24.8M 76.4% | $27.2M 78.9% | $30.2M 77.0% | $31.7M 74.9% | $29.1M 75.4% | $25.7M 74.5% |
| Cost of Products | — | — | — | — | — | — | — | — | $12.1M 31.4% | $11.0M 31.9% |
| Gross Profit | $9.1M 25.1% | $10.8M 25.4% | $11.7M 27.1% | $11.7M 26.6% | $7.7M 23.6% | $7.3M 21.1% | $9.0M 23.0% | $10.6M 25.1% | $9.5M 24.6% | $8.8M 25.5% |
| Research & Development | $384K 1.1% | $392K 0.9% | $397K 0.9% | $375K 0.9% | $357K 1.1% | $355K 1.0% | $345K 0.9% | $451K 1.1% | $208K 0.5% | $200K 0.6% |
| Selling, General & Admin | $7.9M 21.6% | $8.4M 19.8% | $8.4M 19.4% | $8.4M 19.0% | $6.9M 21.3% | $7.1M 20.5% | $7.0M 18.0% | $7.3M 17.1% | $6.9M 17.9% | $6.4M 18.7% |
| Total Operating Expenses | $8.9M 24.4% | $9.7M 22.9% | $9.5M 21.9% | $9.4M 21.3% | $7.7M 23.8% | $8.2M 23.8% | $8.2M 20.9% | $8.4M 19.9% | $8.0M 20.7% | $7.3M 21.2% |
| Operating Income | $254K 0.7% | $1.1M 2.6% | $2.2M 5.2% | $2.4M 5.3% | -$61K -0.2% | $879K 2.6% | $1.5M 3.9% | $1.2M 2.8% | $1.3M 3.4% | $788K 2.3% |
| Interest Expense | $45K 0.1% | $77K 0.2% | $105K 0.2% | $122K 0.3% | $126K 0.4% | $230K 0.7% | $319K 0.8% | $233K 0.6% | $202K 0.5% | $204K 0.6% |
| Other Income (Expense), net | -$81K -0.2% | $536K 1.3% | $154K 0.4% | $701K 1.6% | -$838K -2.6% | $2.1M 6.0% | $615K 1.6% | $102K 0.2% | $312K 0.8% | -$158K -0.5% |
| Pretax Income | $173K 0.5% | $1.6M 3.8% | $2.4M 5.5% | $3.1M 6.9% | -$899K -2.8% | $1.1M 3.2% | $1.4M 3.6% | $2.3M 5.4% | $1.8M 4.7% | $1.3M 3.8% |
| Income Tax Expense | $168K 0.5% | $486K 1.1% | $622K 1.4% | $757K 1.7% | $228K 0.7% | -$12K -0.0% | -$42K -0.1% | $987K 2.3% | $341K 0.9% | $237K 0.7% |
| Net Income | -$41K -0.1% | $1.1M 2.5% | $1.5M 3.6% | $2.4M 5.4% | -$591K -1.8% | $878K 2.5% | $1.5M 3.9% | $1.2M 2.8% | $1.3M 3.4% | $779K 2.3% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.01 | $0.25 | $0.38 | $0.60 | $-0.16 | $0.24 | $0.42 | $0.33 | $0.38 | $0.22 |
| EPS (Diluted) | $-0.01 | $0.24 | $0.37 | $0.57 | $-0.15 | $0.24 | $0.41 | $0.31 | $0.36 | $0.22 |
| Weighted Avg Shares (Basic) | 4.3M | 4.2M | 4.1M | 4.0M | 3.8M | 4K | 3.7M | 3.6M | 3.5M | 3.5M |
| Weighted Avg Shares (Diluted) | 4.4M | 4.3M | 4.2M | 4.2M | 3.9M | 4K | 3.8M | 3.8M | 3.6M | 3.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 26 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 5.6× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 74.9 | 77.0 | 78.9 | 76.4 | 73.4 | 72.9 | 74.6 | 74.9 |
| Gross Profit | 25.1 | 23.0 | 21.1 | 23.6 | 26.6 | 27.1 | 25.4 | 25.1 |
| R&D | 1.1 | 0.9 | 1.0 | 1.1 | 0.9 | 0.9 | 0.9 | 1.1 |
| SG&A | 17.1 | 18.0 | 20.5 | 21.3 | 19.0 | 19.4 | 19.8 | 21.6 |
| Operating Income | 2.8 | 3.9 | 2.6 | -0.2 | 5.3 | 5.2 | 2.6 | 0.7 |
| Income Tax | 2.3 | -0.1 | -0.0 | 0.7 | 1.7 | 1.4 | 1.1 | 0.5 |
| Net Income | 2.8 | 3.9 | 2.5 | -1.8 | 5.4 | 3.6 | 2.5 | -0.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TRT: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 743 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSM | $10.83T | — | — | — | — | — | — | — | — | — | 3,121 |
| NVDA | $5.20T | 43.6× | 39.0× | 24.1× | 65.5% | 71.1% | 55.6% | 76.3% | 72.4% | 0.1× | 5,582 |
| AAPL | $4.91T | 44.6× | 34.3× | 11.8× | 6.4% | 46.9% | 26.9% | 152% | 68.1% | 0.6× | 5,858 |
| MSFT | $3.64T | 27.3× | 19.3× | 11.0× | 17.8% | 67.9% | 40.3% | 30.2% | 27.7% | 0.2× | 5,944 |
| AVGO | $1.61T | 71.2× | 63.6× | 25.2× | 23.9% | 67.8% | 36.2% | 28.4% | 15.8% | 2.5× | 4,442 |
| MU | $1.04T | 122.1× | 57.5× | 27.8× | 48.9% | 39.8% | 22.8% | 15.8% | 12.9% | 0.7× | 2,894 |
| AMD | $835.4B | 193.4× | 197.6× | 24.1× | 34.3% | 49.5% | 12.5% | 6.9% | 6.5% | 0.8× | 3,059 |
| INTC | $504.6B | — | 62.9× | 9.6× | -0.5% | 34.8% | -0.5% | -0.2% | -0.2% | 5.5× | 2,495 |
| CSCO | $426.7B | 42.3× | 35.8× | 7.5× | 5.3% | 64.9% | 18.0% | 21.7% | 13.6% | 2.3× | 3,560 |
| PLTR | $416.9B | 276.7× | 288.5× | 93.2× | 56.2% | 82.4% | 36.3% | 22.0% | 22.0% | — | 2,883 |
| DELL | $367.3B | 64.9× | 34.6× | 3.2× | 18.8% | 20.0% | 5.2% | -240% | 20.4% | 2.8× | 1,564 |
| LRCX | $341.6B | 64.9× | 54.5× | 18.5× | 23.7% | 48.7% | 29.1% | 54.3% | 37.4% | 0.7× | 2,500 |
| AMAT | $329.4B | 48.0× | 37.9× | 11.6× | 4.4% | 48.7% | 24.7% | 34.3% | 25.9% | 0.8× | 2,826 |
| RPAY | $325.1B | — | — | 1051.3× | -1.2% | 75.0% | -83.0% | -53.0% | -28.2% | -1.7× | 142 |
| UMC | $283.0B | — | — | — | — | — | — | — | — | — | 302 |
| SAP | $261.9B | — | — | — | — | — | — | — | — | — | 794 |
| ARM | $259.6B | 287.0× | 223.6× | 52.8× | 22.8% | 97.5% | 18.4% | 10.9% | 10.9% | — | 730 |
| PANW | $250.9B | 234.8× | 156.8× | 27.2× | 14.9% | 73.4% | 12.3% | 14.5% | 14.5% | — | 2,374 |
| ANET | $248.2B | 71.8× | 62.7× | 27.6× | 28.6% | 64.1% | 39.0% | 28.4% | 28.4% | — | 1,930 |
| TXN | $236.9B | 47.8× | 31.2× | 13.4× | 13.0% | 57.0% | 28.3% | 30.7% | 16.5% | 1.8× | 2,345 |
| CRM | $232.8B | 32.1× | 25.2× | 5.6× | 9.6% | 77.7% | 18.0% | 12.6% | 10.1% | 1.5× | 2,547 |
| IBM | $222.5B | 21.3× | — | 3.3× | 7.6% | 58.2% | 15.7% | 32.4% | 11.3% | — | 3,351 |
| SNDK | $221.9B | — | — | 30.2× | 10.4% | 30.1% | -22.3% | -17.8% | -14.8% | -1.5× | 1,127 |
| QCOM | $198.5B | 36.9× | 14.9× | 4.5× | 13.7% | 55.4% | 12.5% | 26.1% | 15.4% | 1.1× | 2,611 |
| MRVL | $194.6B | 74.8× | 127.2× | 23.8× | 42.1% | 51.0% | 32.6% | 18.7% | 14.2% | 2.9× | 1,477 |
| TRT | $87M | — | 25.6× | 2.4× | -13.8% | 25.1% | -0.1% | -0.1% | -0.1% | 0.2× | 26 |
Peers = companies sharing TRT's sector (Technology) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.